FDA Inspection 1256044 — Co-Innovation Biotech Co., Ltd.
The FDA completed an inspection of Co-Innovation Biotech Co., Ltd. on November 14, 2024 in Guangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 14, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Guangzhou (China)